Department of Neurobiology, Physiology and Behavior University of California, Davis, CA, USA.
Nicotine Tob Res. 2022 Feb 14;24(3):306-315. doi: 10.1093/ntr/ntab086.
Ingestion of nicotine by smoking, vaping, or other means elicits various effects including reward, antinociception, and aversion due to irritation, bitter taste, and unpleasant side effects such as nausea and dizziness.
Here we review the sensory effects of nicotine and the underlying neurobiological processes.
Nicotine elicits oral irritation and pain via the activation of neuronal nicotinic acetylcholine receptors (nAChRs) expressed by trigeminal nociceptors. These nociceptors excite neurons in the trigeminal subnucleus caudalis (Vc) and other brainstem regions in a manner that is significantly reduced by the nAChR antagonist mecamylamine. Vc neurons are excited by lingual application of nicotine and exhibit a progressive decline in firing to subsequent applications, consistent with desensitization of peripheral sensory neurons and progressively declining ratings of oral irritation in human psychophysical experiments. Nicotine also elicits a nAChR-mediated bitter taste via excitation of gustatory afferents. Nicotine solutions are avoided even when sweeteners are added. Studies employing oral self-administration have yielded mixed results: Some studies show avoidance of nicotine while others report increased nicotine intake over time, particularly in adolescents and females. Nicotine is consistently reported to increase human pain threshold and tolerance levels. In animal studies, nicotine is antinociceptive when delivered by inhalation of tobacco smoke or systemic infusion, intrathecally, and by intracranial microinjection in the pedunculopontine tegmentum, ventrolateral periaqueductal gray, and rostral ventromedial medulla. The antinociception is thought to be mediated by descending inhibition of spinal nociceptive transmission. Menthol cross-desensitizes nicotine-evoked oral irritation, reducing harshness that may account for its popularity as a flavor additive to tobacco products.
Nicotine activates brain systems underlying reward and antinociception, but at the same time elicits aversive sensory effects including oral irritation and pain, bitter taste, and other unpleasant side effects mediated largely by nicotinic acetylcholine receptors (nAChRs). This review discusses the competing aversive and antinociceptive effects of nicotine and exposure to tobacco smoke, and the underlying neurobiology. An improved understanding of the interacting effects of nicotine will hopefully inform novel approaches to mitigate nicotine and tobacco use.
通过吸烟、蒸气或其他方式摄入尼古丁会产生各种效果,包括奖励、镇痛和因刺激、苦味和恶心、头晕等不良副作用引起的厌恶。
在这里,我们回顾了尼古丁的感官效应和潜在的神经生物学过程。
尼古丁通过激活三叉神经伤害感受器表达的神经元烟碱型乙酰胆碱受体(nAChR)引起口腔刺激和疼痛。这些伤害感受器以一种方式兴奋三叉神经尾核(Vc)和其他脑干区域的神经元,这种方式可以通过烟碱型乙酰胆碱受体拮抗剂美加明显著减少。舌部应用尼古丁会兴奋 Vc 神经元,并表现出对随后应用的放电逐渐减少,这与外周感觉神经元的脱敏以及人类心理物理学实验中口腔刺激评分的逐渐下降相一致。尼古丁还通过兴奋味觉传入纤维引起烟碱型乙酰胆碱受体介导的苦味。即使添加了甜味剂,也会避免使用尼古丁溶液。采用口腔自我给药的研究得出了混合的结果:一些研究表明避免尼古丁,而另一些研究报告随着时间的推移,尼古丁摄入量增加,尤其是在青少年和女性中。尼古丁一直被报道能增加人类疼痛阈值和耐受水平。在动物研究中,通过吸入烟草烟雾或全身输注、鞘内注射以及在pedunculopontine tegmentum、ventrolateral periaqueductal gray 和 rostral ventromedial medulla 中进行颅内微注射,尼古丁具有镇痛作用。这种镇痛作用被认为是通过脊髓伤害性传递的下行抑制介导的。薄荷醇交叉脱敏尼古丁引起的口腔刺激,减轻了其刺鼻感,这可能是它作为烟草产品调味剂受欢迎的原因。
尼古丁激活了奖励和镇痛的大脑系统,但同时也引起了厌恶的感觉效应,包括口腔刺激和疼痛、苦味和其他不愉快的副作用,这些副作用主要由烟碱型乙酰胆碱受体(nAChR)介导。这篇综述讨论了尼古丁和接触烟草烟雾的厌恶和镇痛作用,以及潜在的神经生物学。对尼古丁相互作用效应的深入了解有望为减轻尼古丁和烟草使用提供新的方法。